Just the News, No Noise
FDA approves Pfizer’s nasal spray for migraines
The Food and Drug Administration has approved Pfizer’s new nasal spray for treating migraines. The drug company says Zavzpret is considered a rapid rescue treatment and can relieve migraine pain within fifteen minutes.
Top Stories
Trending
- Barry Loudermilk confirms pipe bomb suspect confessed to planting devices near DNC, RNC headquarters
- Watch: Former British PM Liz Truss’ first show: London is Falling
- DOJ tries to shut down Pfizer clinical trial whistleblower after FDA admits COVID vax killed kids
- Indiana House approves 9-0 congressional map
- DHS pushes back on new Dem Rep's claim of being pepper-sprayed in Tucson raid